Congenital Hypothyroidism-Role of Clinical Laboratory from Screening to Follow up

Authors

  • Smita Sharma Associate Professor Biochemistry, M.M.Institute of Medical Sciences and Research, Mullana, Ambala, India Author
  • Rami Abdullah Ali Al Daghreer Ministry of Health, Nejran. KSA Author
  • Hamad Al Daghreer Ministry of Health, Nejran. KSA Author

DOI:

https://doi.org/10.67224/ioasdjmps.2026.v03i03.014

Keywords:

Congenital Hypothyroidism, Neonatal Screening, Thyroid Stimulating Hormone, Free Thyroxine, Clinical Laboratory, ISPAE

Abstract

Background: Congenital hypothyroidism represents a leading preventable cause of cognitive impairment. Indian data shows an incidence of 1:800 to 1: 1700 new-borns. Objectives: The review outlines the contribution of clinical laboratories in congenital hypothyroidism detection, confirmation and longitudinal monitoring according to current ISPAE and AAP recommendations. Conclusion: Establishing universal cord blood screening with defined alert limits and fast reporting can ensure therapy starts within the first 48 hours.

Downloads

Published

2026-08-22

Issue

Section

Review Articles

How to Cite

Smita Sharma, Rami Abdullah Ali Al Daghreer, & Hamad Al Daghreer. (2026). Congenital Hypothyroidism-Role of Clinical Laboratory from Screening to Follow up. IOASD Journal of Medical and Pharmaceutical Sciences, 3(3), 194-195. https://doi.org/10.67224/ioasdjmps.2026.v03i03.014